Roth Capital lowered shares of CareCloud (NASDAQ:CCLD – Free Report) from a strong-buy rating to a hold rating in a research report released on Wednesday,Zacks.com reports.
Several other equities research analysts have also recently issued reports on CCLD. Benchmark lifted their target price on CareCloud from $4.00 to $4.50 and gave the stock a “buy” rating in a report on Tuesday, August 27th. Roth Mkm lowered shares of CareCloud from a “buy” rating to a “neutral” rating and lowered their price target for the company from $5.00 to $3.50 in a report on Wednesday.
View Our Latest Research Report on CareCloud
CareCloud Trading Down 17.4 %
CareCloud (NASDAQ:CCLD – Get Free Report) last issued its earnings results on Tuesday, August 13th. The company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.07 by $0.10. The business had revenue of $28.09 million during the quarter, compared to analyst estimates of $27.89 million. CareCloud had a negative return on equity of 90.27% and a negative net margin of 35.25%. As a group, equities analysts forecast that CareCloud will post 0.58 EPS for the current fiscal year.
Institutional Inflows and Outflows
An institutional investor recently raised its position in CareCloud stock. Renaissance Technologies LLC boosted its position in shares of CareCloud, Inc. (NASDAQ:CCLD – Free Report) by 25.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 107,200 shares of the company’s stock after purchasing an additional 21,500 shares during the period. Renaissance Technologies LLC owned approximately 0.66% of CareCloud worth $206,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 10.16% of the company’s stock.
About CareCloud
CareCloud, Inc, a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services.
Featured Articles
- Five stocks we like better than CareCloud
- Retail Stocks Investing, Explained
- Top 3 R&D-Driven Stocks Showing Strong Profit and Momentum
- What Are Some of the Best Large-Cap Stocks to Buy?
- Shopify Stock Rally Continues: Why the Growth Story Isn’t Over
- EV Stocks and How to Profit from Them
- Tariff Troubles: 3 Stocks Planning Higher Prices
Receive News & Ratings for CareCloud Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareCloud and related companies with MarketBeat.com's FREE daily email newsletter.